Espinoza Octavio Insider Trades

Insider Trading History

Track insider trading activity for Espinoza Octavio. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $5.16M 17,407 shares
Last Trade
May 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$410k 1,736 shares
$235.89
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $8.2M 27,679 shares
Last Trade
May 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$410k 1,736 shares
$235.89
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 11, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$532k 2,405 shares
$221.24
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $7.13M 24,067 shares
Last Trade
Mar 11, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$532k 2,405 shares
$221.24
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $6.22M 21,010 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$688k 3,057 shares
$225.00
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $10.2M 34,386 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.76M 13,423 shares
$205.83
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$433k 2,073 shares
$208.95
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $10.4M 35,085 shares
Last Trade
Mar 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$433k 2,073 shares
$208.95
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $11.2M 37,945 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.76M 28,460 shares
$202.55
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $10.5M 35,505 shares
Last Trade
Feb 15, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$647k 3,519 shares
$183.83
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $10.8M 36,531 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.52M 8,244 shares
$183.83
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $12.2M 41,014 shares
Last Trade
Feb 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.98M 16,200 shares
$183.83
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $8.47M 28,575 shares
Last Trade
Dec 31, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.51k 8 shares
$189.07
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $5.38M 18,171 shares
Last Trade
Dec 16, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$459k 2,381 shares
$192.63
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $8.46M 28,567 shares
Last Trade
Dec 16, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$459k 2,381 shares
$192.63
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $7.76M 26,186 shares
Last Trade
Dec 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$340k 1,804 shares
$188.31
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $8.29M 27,990 shares
Last Trade
Dec 05, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$344k 1,862 shares
$184.87
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $8.84M 29,852 shares
Last Trade
Jun 30, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$25.5k 224 shares
$113.68
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $8.28M 27,932 shares
Last Trade
May 09, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$156k 1,500 shares
$104.06
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Financial Officer
Holding Value $9.69M 32,717 shares
Last Trade
Mar 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.77M 32,717 shares
$115.26
$296.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up